199 related articles for article (PubMed ID: 34083030)
21. Taking time.
Gilbey J
Nature; 2023 Oct; ():. PubMed ID: 37821606
[No Abstract] [Full Text] [Related]
22. Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.
Komen JJ; Pottegård A; Mantel-Teeuwisse AK; Forslund T; Hjemdahl P; Wettermark B; Hellfritzsch M; Hallas J; Olesen M; Bennie M; Mueller T; Voss A; Schink T; Haug U; Kollhorst B; Karlstad Ø; Kjerpeseth LJ; Klungel OH
Europace; 2021 Nov; 23(11):1722-1730. PubMed ID: 34096584
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database.
Guo M; Thai S; Zhou J; Wei J; Zhao Y; Xu W; Wang T; Cui X
Int J Clin Pharm; 2021 Dec; 43(6):1508-1515. PubMed ID: 34109494
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
[TBL] [Abstract][Full Text] [Related]
25. Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis.
Shen NN; Zhang C; Hang Y; Li Z; Kong LC; Wang N; Wang JL; Gu ZC
Front Pharmacol; 2021; 12():581293. PubMed ID: 34122056
[No Abstract] [Full Text] [Related]
26. Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
Lee HJ; Kim HK; Kim BS; Han KD; Park JB; Lee H; Lee SP; Kim YJ
PLoS One; 2021; 16(6):e0253310. PubMed ID: 34138972
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulation in Very Old Patients with Atrial Fibrillation (AVOPA): A Descriptive Observational Study.
Hupfer M; Gosch M
Drugs Real World Outcomes; 2021 Dec; 8(4):603-614. PubMed ID: 34115332
[TBL] [Abstract][Full Text] [Related]
28. The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused.
Rubboli A; Atar D
Eur J Intern Med; 2021 Aug; 90():125-126. PubMed ID: 34090747
[No Abstract] [Full Text] [Related]
29. Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life.
Zappulla P; Calvi V
TH Open; 2021 Apr; 5(2):e200-e210. PubMed ID: 34151138
[TBL] [Abstract][Full Text] [Related]
30. Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
Benamouzig R; Guenoun M; Deutsch D; Fauchier L
Cardiovasc Drugs Ther; 2022 Oct; 36(5):973-989. PubMed ID: 34143317
[TBL] [Abstract][Full Text] [Related]
31. Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study.
Chen IC; Chang WT; Hsu PC; Yeh YL; Zheng S; Huang YC; Lin CH; Tsai LM; Lin LJ; Liu PY; Liu YW
Medicine (Baltimore); 2021 Jun; 100(23):e26272. PubMed ID: 34115024
[TBL] [Abstract][Full Text] [Related]
32. Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage.
Vestal ML; Hodulik K; Mando-Vandrick J; James ML; Ortel TL; Fuller M; Notini M; Friedland M; Welsby IJ
J Thromb Thrombolysis; 2022 Jan; 53(1):167-175. PubMed ID: 34101050
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic Therapy With or Without Aspirin After Percutaneous Coronary Intervention or Acute Coronary Syndrome in Patients Taking Oral Anticoagulation: A Meta-Analysis and Network Analysis of Randomized Controlled Trials.
Colleran R; Byrne RA; Ndrepepa G; Alvarez-Covarrubias HA; Mayer K; Kuna C; Rai H; Kastrati A; Cassese S
Cardiovasc Revasc Med; 2022 Mar; 36():99-106. PubMed ID: 34099410
[TBL] [Abstract][Full Text] [Related]
34. A Network Meta-Analysis Comparing Osteoporotic Fracture among Different Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation.
Khanra D; Mukherjee A; Deshpande S; Khan H; Kathuria S; Kella D; Padmanabhan D
J Bone Metab; 2021 May; 28(2):139-150. PubMed ID: 34130366
[TBL] [Abstract][Full Text] [Related]
35. Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice.
Roberti R; Iannone LF; Palleria C; Curcio A; Rossi M; Sciacqua A; Armentaro G; Vero A; Manti A; Cassano V; Russo E; De Sarro G; Citraro R
Front Pharmacol; 2021; 12():684638. PubMed ID: 34122113
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
He T; Han F; Wang J; Hu Y; Zhu J
PLoS One; 2021; 16(6):e0250096. PubMed ID: 34138850
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials.
Galli M; Capodanno D; Benenati S; D'Amario D; Crea F; Andreotti F; Angiolillo DJ
Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):519-528. PubMed ID: 34146091
[TBL] [Abstract][Full Text] [Related]
38. Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?
Smythe MA; Burns C; Liu Q; Garwood CL
Ann Pharmacother; 2022 Mar; 56(3):319-329. PubMed ID: 34137279
[TBL] [Abstract][Full Text] [Related]
39. Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation - K-PLUS registry.
Nakajima M; Inatomi Y; Ueda A; Ito Y; Kouzaki Y; Takita T; Wada K; Yonehara T; Terasaki T; Hashimoto Y; Ando Y
J Clin Neurosci; 2021 Jul; 89():106-112. PubMed ID: 34119252
[TBL] [Abstract][Full Text] [Related]
40. Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Minematsu K; Miyamoto S; Murakawa Y; Iwashiro S; Okayama Y; Sunaya T; Hirano K; Hayasaki T
PLoS One; 2021; 16(6):e0251325. PubMed ID: 34115769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
